- Home
- CTRI vs CNTA Comparison
CTRI vs CNTA Comparison
Compare CTRI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRI
- CNTA
- Stock Information
- Founded
- CTRI 1909
- CNTA 2020
- Country
- CTRI United States
- CNTA United Kingdom
- Employees
- CTRI N/A
- CNTA N/A
- Industry
- CTRI
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- CTRI
- CNTA Health Care
- Exchange
- CTRI Nasdaq
- CNTA Nasdaq
- Market Cap
- CTRI 1.8B
- CNTA 1.6B
- IPO Year
- CTRI 2024
- CNTA 2021
- Fundamental
- Price
- CTRI $21.21
- CNTA $14.29
- Analyst Decision
- CTRI Hold
- CNTA Strong Buy
- Analyst Count
- CTRI 6
- CNTA 10
- Target Price
- CTRI $19.50
- CNTA $28.78
- AVG Volume (30 Days)
- CTRI 1.1M
- CNTA 992.4K
- Earning Date
- CTRI 07-28-2025
- CNTA 08-12-2025
- Dividend Yield
- CTRI N/A
- CNTA N/A
- EPS Growth
- CTRI N/A
- CNTA N/A
- EPS
- CTRI 0.00
- CNTA N/A
- Revenue
- CTRI $2,659,287,000.00
- CNTA $15,000,000.00
- Revenue This Year
- CTRI $5.94
- CNTA N/A
- Revenue Next Year
- CTRI $5.40
- CNTA N/A
- P/E Ratio
- CTRI $4,675.85
- CNTA N/A
- Revenue Growth
- CTRI N/A
- CNTA 118.88
- 52 Week Low
- CTRI $14.46
- CNTA $9.00
- 52 Week High
- CTRI $24.60
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- CTRI N/A
- CNTA 61.38
- Support Level
- CTRI N/A
- CNTA $13.22
- Resistance Level
- CTRI N/A
- CNTA $14.74
- Average True Range (ATR)
- CTRI 0.00
- CNTA 0.73
- MACD
- CTRI 0.00
- CNTA 0.14
- Stochastic Oscillator
- CTRI 0.00
- CNTA 85.11
About CTRI Centuri Holdings Inc. Common Stock
Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings primarily consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. They operate under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.